Effect of growth hormone replacement therapy on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone-deficient adults

Journal of Lipid Research

Volumn 41, Issue 6, 2000, Pages 925-932

  Beentjes, John A M ^a   Van Tol, Arie ^a   Sluiter, Wim J ^a   Dullaart, Robin P F ^a  

^a NONE

Author keywords

CETP; Cholesterol esterification; Cholesteryl ester transfer; Growth hormone deficiency; Growth hormone replacement; HDL; LCAT; PLTP

Indexed keywords

ACYLTRANSFERASE; APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL ESTER TRANSFER PROTEIN; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL ESTERIFICATION; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIPID TRANSPORT; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; PRIORITY JOURNAL; PROTEIN TRANSPORT;

ADULT; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; DEFICIENCY DISEASES; GLYCOPROTEINS; GROWTH HORMONE; HUMANS; MIDDLE AGED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PLACEBOS;

EID: 0033920675     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Rosén, T., and B. Å. Bengtsson. 1990. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 336: 285-288.
2. Bates, A. S., W. Van't Hoff, P. J. Jones, and R. N. Clayton. 1996. The effect of hypopituitarism on life expectancy. J. Clin. Endocrinol. Metab. 81: 1169-1172.
3. Bülow, B., L. Hagmar, Z. Mikoczy, C. H. Nordström, and E. M. Erfurth. 1997. Increased cerebrovascular mortality in patients with hypopituitarism. Clin. Endocrinol. 46: 75-81.
4. Markussis, V., S. A. Beshyah, C. Fisher, P. Sharp, A. N. Nicolaides, and D. G. Johnston. 1992. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet. 340: 1188-1192.
5. Carroll, P. V., E. R. Christ, B. Å. Bengtsson, L. Carlsson, J. S. Christiansen, D. Clemmons, R. Hintz, K. Y. Ho, Z. Laron, P. Sizonenko, P. H. Sönksen, T. Tanaka, and M. O. Thorner. 1998. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J. Clin. Endocrinol. Metab. 83: 382-395.
6. Attanasio, A. F., S. W. J. Lamberts, A. M. C. Matranga, M. A. Birkett, P. C. Bates, N. K. Valk, J. Hilsted, B. Å. Bengtsson, and C. J. Strasburger. 1997. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. J. Clin. Endocrinol. Metab. 82: 82-88.
7. Leese, G. P., M. Wallymahmed, C. VanHeyningen, F. Tames, G. Wieringa, and I. A. MacFarlane. 1998. HDL-cholesterol reductions associated with adult growth hormone replacement. Clin. Endocrinol. 49: 673-677.
8. Bruce, C., and A. R. Tall. 1995. Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis. Curr. Opin. Lipidol. 6: 306-311.
9. Fielding, C. J., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228.
10. Eisenberg, S. 1984. High density lipoprotein metabolism. J. Lipid Res. 25: 1017-1058.
11. Dullaart, R. P. F., J. E. M. Groener, and D. W. Erkelens. 1991. Cholesteryl ester transfer between lipoproteins. Diab. Nutr. Metab. 4: 329-343.
12. Tall, A. R. 1993. Plasma cholesteryl ester transfer protein. J. Lipid Res. 34: 1255-1274.
13. Jauhiainen, M., J. Metso, R. Pahlman, S. Blomqvist, A. Van Tol, and C. Ehnholm. 1993. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J. Biol. Chem. 268: 4032-4036.
14. Tu, A. Y., H. I. Nishida, and T. Nishida. 1993. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J. Biol. Chem. 268: 23098-23105.
15. Lagrost, L., C. Desrumaux, D. Masson, V. Deckert, and P. Gambert. 1998. Structure and function of the plasma phospholipid transfer protein. Curr. Opin. Lipidol. 9: 203-209.
16. Von Eckardstein, A., M. Jauhiainen, Y. Huang, J. Metso, C. Langer, P. Pussinen, S. Wu, C. Ehnholm, and G. Assmann. 1996. Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL. Biochim. Biophys. Acta. 1301: 255-262.
17. Tan, K. C. B., S. W. M. Shiu, E. D. Janus, and K. S. Lam. 1997. LDL subfractions in acromegaly: relation to growth hormone and insulin-like growth factor-I. Atherosclerosis. 129: 59-65.
18. Beentjes, J. A. M., A. Van Tol, W. J. Sluiter, and R. P. F. Dullaart. 1999. Low plasma lecithin:cholesterol acyl transferase and lipid transfer protein activities in growth hormone deficient and acromegalic men: role in altered high density lipoproteins. 28th International Symposium GH and Growth Factors in Endocrinology and Metabolism, Boston, MA.
19. Beentjes, J. A. M., G. Tjeerdsma, W. J. Sluiter, and R. P. F. Dullaart. 1996. Divergence between growth hormone responses to insulin-induced hypoglycaemia and growth hormone-releasing hormone in patients with non-functioning pituitary macroadenomas and hyperprolactinaemia. Clin. Endocrinol. 45: 391-398.
20. Ostlund, R. E., Jr., M. Staten, W. M. Kohrt, J. Schultz, and M. Malley. 1990. The ratio of waist-to-hip circumference, plasma insulin level, and glucose intolerance as independent predictors of the HDL2 cholesterol level in older adults. N. Engl. J. Med. 322: 229-234.
21. Lukaski, H. C., P. E. Johnson, W. W. Bolonchuk, and G. I. Lykken. 1985. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am. J. Clin. Nutr. 41: 810-817.
22. Demacker, P. N., A. G. Hijmans, H. E. Vos-Janssen, A. Van't Laar, and A. P. Jansen. 1980. A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein. Clin. Chem. 26: 1775-1779.
23. Hindriks, F. R., B. G. Wolthers, and A. Groen. 1977. The determination of total cholesterol in serum by gas-liquid chromatography compared with two other methods. Clin. Chim. Acta. 74: 207-215.
24. Dullaart, R. P. F., W. J. Sluiter, L. D. Dikkeschei, K. Hoogenberg, and A. Van Tol. 1994. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur. J. Clin. Invest. 24: 188-194.
25. Groener, J. E. M., R. W. Pelton, and G. M. Kostner. 1986. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin. Chem. 32: 283-286.
26. Floren, C. H., C. H. Chen, J. Franzen, and J. J. Albers. 1987. Lecithin: cholesterol acyltransferase in liver disease. Scand. J. Clin. Lab. Invest. 47: 613-617.
27. Hannuksela, M., Y. L. Marcel, Y. A. Kesaniemi, and M. J. Savolainen. 1992. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J. Lipid Res. 33: 737-744.
28. Speijer, H., J. E. M. Groener, E. Van Ramshorst, and A. Van Tol. 1991. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis. 90: 159-168.
29. Channon, K. M., R. J. Clegg, D. Bhatnagar, M. Ishola, S. Arrol, and P. N. Durrington. 1990. Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transfer. Atherosclerosis. 80: 217-226.
30. Dullaart, R. P. F., S. C. Riemens, L. M. Scheek, and A. Van Tol. 1999. Insulin decreases plasma cholesterylester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes. Eur. J. Clin. Invest. 29: 663-671.
31. Sutherland, W. H., R. J. Walker, N. J. Lewis-Barned, H. Pratt, and H. C. Tillman. 1994. Plasma cholesteryl ester transfer in patients with non-insulin dependent diabetes mellitus. Clin. Chim. Acta. 231: 29-38.
32. Salomon, F., R. C. Cuneo, R. Hesp, and P. H. Sönksen. 1989. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N. Engl. J. Med. 321: 1797-1803.
33. Binnerts, A., G. R. Swart, J. H. P. Wilson, N. Hoogerbrugge, H. A. P. Pols, J. C. Birkenhager, and S. W. J. Lamberts. 1992. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin. Endocrinol. 37: 79-87.
34. Whitehead, H. M., C. Boreham, E. M. McIlrath, B. Sheridan, L. Kennedy, A. B. Atkinson, and D. R. Hadden. 1992. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin. Endocrinol. 36: 45-52.
35. Cuneo, R. C., F. Salomon, G. F. Watts, R. Hesp, and P. H. Sönksen. 1993. Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism. 42: 1519-1523.
36. Eden, S., O. Wiklund, J. Oscarsson, T. Rosén, and B. Å. Bengtsson. 1993. Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp[a] and HDL cholesterol concentrations. Arterioscler. Thromb. 13: 296-301.
37. Beshyah, S. A., A. Henderson, R. Niththyananthan, E. Skinner, V. Anyaoku, W. Richmond, P. Sharp, and D. G. Johnston. 1995. The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. J. Clin. Endocrinol. Metab. 80: 356-363.
38. Gibney, J., J. D. Wallace, T. Spinks, L. Schnorr, A. Ranicar, R. C. Cuneo, S. Lockhart, K. G. Burnand, F. Salomon, P. H. Sönksen, and D. L. Russell-Jones. 1999. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients. J. Clin. Endocrinol. Metab. 84: 2596-2602.
39. De Boer, H., G. J. Blok, C. Popp-Snijders, L. Stuurman, R. C. Baxter, and E. A. Van der Veen. 1996. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. J. Clin. Endocrinol. Metab. 81: 1371-1377.
40. Russell-Jones, D. L., G. F. Watts, A. J. Weissberger, R. Naoumova, J. Myers, G. R. Thompson, and P. H. Sönksen. 1991. The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. Clin. Endocrinol. 41: 345-350.
41. Weaver, J. U., J. P. Monson, K. Noonan, W. G. John, A. Edwards, K. A. Evans, and J. Cunningham. 1995. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. J. Clin. Endocrinol. Metab. 80: 153-159.
42. Johannsson, G., J. Oscarsson, T. Rosén, O. Wiklund, G. Olsson, L. Wilhelmsen, and B. Å. Bengtsson. 1995. Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Arterioscler. Thromb. Vasc. Biol. 15: 2142-2150.
43. Al-Shoumer, K. A. S., R. Gray, V. Anyaoku, C. L. Hughes, S. Beshyab. 1998. Effects of four years' treament with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clin. Endocrinol. 48: 795-802.
44. Garry, P., P. Collins, and J. G. Devlin. 1996. An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency. Eur. J. Endocrinol. 134: 61-66.
45. Norum, K. R. 1973. The role of lecithin: cholesterol acyltransferase in the metabolism of plasma lipoproteins. Ann. Biol. Clin. 31: 123-125.
46. Radeau, T., M. Robb, P. Lau, J. Borthwick, and R. McPherson. 1998. Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man. Atherosclerosis. 139: 369-376.
47. Rudling, M., G. Norstedt, H. Olivecrona, E. Reihnér, J. Å. Gustafsson, and B. Angelin. 1992. Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc. Natl. Acad. Sci. USA. 89: 6983-6987.
48. Christ, E., M. H. Cummings, E. Albany, A. M. Umpleby, P. J. Lumb, A. Wierzbicki, R. Naoumova, M. A. Boroujerdi, P. H. Sönksen, and D. L. Russell-Jones. 1999. Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: a stable isotope study. J. Clin. Endocrinol. Metab. 84: 307-316.
49. Tall, A. R. 1986. Plasma lipid transfer proteins. J. Lipid Res. 27: 361-367.
50. Ahnadi, C. E., F. Berthezene, and G. Ponsin. 1993. Simvastatin-induced decrease in the transfer of cholesterol esters from high density lipoproteins to very low and low density lipoproteins in normolipidemic subjects. Atherosclerosis. 99: 219-228.
51. Riemens, S. C., A. Van Tol, W. J. Sluiter, and R. P. F. Dullaart. 1998. Elevated plasma rholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein. Atherosclerosis. 140: 71-79.
52. Riemens, S. C., A. Van Tol, W. J. Sluiter, and R. P. F. Dullaart. 1999. Acute and chronic effects of a 24-hour intravenous triglyceride emulsion challenge on plasma lecithin:cholesterol acyltransferase, phospholipid transfer protein, and cholesteryl ester transfer protein activities. J. Lipid Res. 40: 1459-1466.
53. Beentjes, J. A. M., A. Van Tol, W. J. Sluiter, and R. P. F. Dullaart. 1999. Decreased plasma cholesterol esterification and cholesteryl ester transfer in hypopituitary patients on glucocorticoid replacement therapy. 28th International Symposium GH and Growth Factors in Endocrinology and Metabolism, Boston, MA. Abstract C4, p 83.
54. Tall, A. R., E. Granot, R. Brocia, I. Tabas, C. B. Hesler, K. Williams, and M. Denke. 1987. Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein. J. Clin. Invest. 79: 1217-1225.
55. Whitlock, M. E., T. L. Swenson, R. Ramakrishnan, M. T. Leonard, Y. L. Marcel, R. W. Milne, and A. R. Tall. 1989. Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit. Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism. J. Clin. Invest. 84: 129-137.
56. Inazu, A., M. L. Brown, C. B. Hesler, L. B. Agellon, J. Koizumi, K. Takata, Y. Maruhama, H. Mabuchi, and A. R. Tall. 1990. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N. Engl. J. Med. 323: 1234-1238.
57. Fielding, C. J., and P. E. Fielding. 1981. Regulation of human plasma lecithin:cholesterol acyltransferase activity by lipoprotein acceptor cholesteryl ester content. J. Biol. Chem. 256: 2102-2104.
58. Oliveira, H. C. F., L. Ma, R. Milne, S. M. Marcovina, A. Inazu, H. Mabuchi, and A. R. Tall. 1997. Cholesteryl ester transfer protein activity enhances plasma cholesteryl ester formation. Studies in CETP transgenic mice and human genetic CETP deficiency. Arterioscler. Thromb. Vasc. Biol. 17: 1045-1052.
59. Asayama, K., S. Amemiya, S. Kusano, and K. Kato. 1984. Growth-hormone-induced changes in postheparin plasma lipoprotein lipase and hepatic triglyceride lipase activities. Metabolism. 33: 129-131.
60. Varban, M. L., F. Rinninger, N. Wang, V. Fairchild-Huntress, J. H. Dunmore, Q. Fang, M. L. Gosselin, K. L. Dixon, J. D. Deeds, S. L. Acton, A. R. Tall, and D. Huszar. 1998. Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc. Natl. Acad. Sci. USA. 95: 4619-4624.
61. Rothblat, G. H., M. De la Llera-Moya, V. Atger, G. Kellner-Weibel, D. L. Williams, and M. C. Phillips. 1999. Cell cholesterol efflux: integration of old and new observations provides new insights. J. Lipid Res. 40: 781-796.
62. Bagdade, J. D., J. T. Lane, P. V. Subbaiah, M. E. Otto, and M. C. Ritter. 1993. Accelerated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus. Atherosclerosis. 104: 69-77.
63. Castro, G. R., and C. J. Fielding. 1988. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry. 27: 25-29.
64. Syvanne, M., G. Castro, C. Dengremont, C. De Geitere, M. Jauhiainen, C. Ehnholm, S. Michelagnoli, G. Franceschini, J. Kahri, and M. R. Taskinen. 1996. Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein. Atherosclerosis. 127: 245-253.
65. 2. A study comparing liver perfusion to in vitro incubation with lipases. J. Biol. Chem. 269: 11572-11577.
66. Fielding, C. J., and R. J. Havel. 1996. Cholesteryl ester transfer protein: friend or foe? J. Clin. Invest. 97: 2687-2688.